Corresponding author.
The purpose of this paper is to re-visit the design of three steps in the freeze-drying process, namely freezing, primary drying, and secondary drying steps. Specifically, up-to-date recommendations for selecting freeze-drying conditions are provided based on the physical–chemical properties of formulations and engineering considerations.
This paper discusses the fundamental factors to consider when selecting freezing, primary drying, and secondary drying conditions, and offers mathematical models for predicting the duration of each segment and product temperature during primary drying. Three simple heat/mass transfer primary drying (PD) models were tested, and their ability to predict product temperature and sublimation time showed good agreement. The PD models were validated based on the experimental data and utilized to tabulate the primary drying conditions for common pharmaceutical formulations, including amorphous and partially crystalline products. Examples of calculated drying cycles, including all steps, for typical amorphous and crystalline formulations are provided.
The authors revisited advice from a seminal paper by Tang and Pikal (Pharm Res. 21(2):191-200, 2004) on selecting freeze-drying process conditions and found that the majority of recommendations are still applicable today. There have been a number of advancements, including methods to promote ice nucleation and computer modeling for all steps of freeze-drying process. The authors created a database for primary drying and provided examples of complete freeze-drying cycles design. The paper may supplement the knowledge of scientists and formulators and serve as a user-friendly tool for quickly estimating the design space.
The online version contains supplementary material available at 10.1007/s11095-023-03607-9.
Received 2023 Mar 20; Accepted 2023 Sep 9; Issue date 2023.
Freeze-drying (lyophilization) is a common pharmaceutical manufacturing process used to produce various drug products. Freeze-drying consists of 3 segments, i.e., freezing, primary drying (ice sublimation), and secondary drying (desorption of unfrozen water), with primary drying (ice sublimation) being the longest. Freezing is a critical stage of a freeze-drying cycle, as the structure and morphology of a frozen cake can influence product behavior during primary drying. Freezing conditions could also majorly impact freeze-dried products' critical quality attributes and shelf life. The primary drying segment typically attracts the most attention because it provides the best opportunity to significantly reduce overall cycle time, while it may also be associated with significant product defects if performed under the wrong conditions.
Furthermore, product behavior during primary drying can be controlled by adjusting heat/mass transfer conditions and is far more predictable than freezing, which depends on a stochastic nucleation process. Acceleration of primary drying requires maintaining a higher product temperature, while product temperature should not exceed a critical product temperature limit to achieve a quality product. Secondary drying, during which an unfrozen fraction of water is removed from the product to achieve a target residual water content level, is usually a relatively straightforward part of freeze-drying.
In a seminal publication by Tang and Pikal[
As “the theater begins with the cloakroom” (as attributed to a famous Russian art director Konstantin Stanislavsky), any freeze-drying recipe begins with the loading temperature. Freeze-dryers are usually loaded at either room temperature (usually 20 to 25°C) or 5°C when liquid stability is a potential concern. On rare occasions, a product is loaded onto shelves cooled below 0°C (e.g., to -50°C); this could be a case when a fast cooling rate is required if there are major concerns with liquid stability or for scheduling reasons in a manufacturing environment to reduce cycle time by eliminating a long cooling step. In such cases, water from the atmosphere could condense on the shelves to form ice, which is highly undesirable.
After loading a freeze-dryer, vials are typically equilibrated for at least 30 min before cooling to minimize vial-to-vial temperature variations. In selecting the shelf cooling rate, one should remember that the shelf temperature/time program is not the same as the product temperature/time response, as illustrated in Fig.
An example of product and shelf temperatures during cooling of a product in a lyophilizer (
As illustrated in Fig.
Lower supercooling (i.e., higher ice nucleation temperature) is considered beneficial, as it is expected to result in larger ice crystals with lower surface area [
Furthermore, it was reported that an increase in the cooling rate from 0.1 to 1000 K/min resulted in only a 2°C difference in the heterogeneous ice nucleation temperature and 4°C in homogeneous ice nucleation [
As noted in [
One approach to eliminating the differences in freezing due to varying degrees of supercooling across a shelf of vials is by employing controlled ice nucleation. The product temperature is reduced below the equilibrium freezing point (or melting temperature). After a brief equilibration, ice nucleation is initiated by a variety of approaches: (i) pressurization and depressurization of the drying chamber [
The use of higher ice nucleation temperatures results in the formation of larger ice crystals, which lead to larger pores post-ice sublimation and a lower cake resistance during drying. Consequently, primary drying duration can be reduced along with decreased inter-vial heterogeneity in drying rates [
Controlled ice nucleation (CIN) could be beneficial for amorphous formulations as it is associated with a lower dry layer resistance and less variability between vials [
Freezing time is important because the material might be partially frozen at this stage, with the freeze-concentrated fraction containing protein in a liquid state. Protein molecules are susceptible to various stresses during this period, including, e.g., freeze-concentration, pH and ionic strength changes, ice/freeze concentrate interface, local mechanical stresses, and protein/cryoprotector phase separation. The freezing time may be reduced by using higher cooling rates, therefore reducing the risk of protein destabilization due to freezing stresses, but one needs to pay attention to a potential increase in heterogeneity of product properties.
Considering that a relatively fast cooling rate would probably have a minimal impact on supercooling and a potential benefit for reducing cycle time, a faster shelf cooling rate can be a logical recommendation for amorphous formulations. In the author's experience, an increase in cooling rate from 0.3 to 1°C/min resulted in a notable improvement of cake appearance for one of the small molecule drugs due to a reduction in phase separation. However, this advice may not apply to formulations with a crystalline bulking agent, as discussed below. The effect of fast cooling has been extensively studied in mannitol solutions, where vial breakage was reported post fast cooling and warming and attributed to mannitol + ice crystallization [
As for commercial cycles, cooling rates of 0.5°C/min or lower are recommended to ensure product temperature homogeneity across freeze-dryer shelves [
Amorphous formulations
In many cases, annealing is applied as a part of the freezing segment. As [
This statement remains valid for the amorphous formulations, clarifying that while annealing may shorten the duration of the primary drying, the overall cycle might still be longer because of the added annealing step. There are also observations that annealing can induce phase separation and skin formation on a frozen cake surface. Annealing increased drying duration due to increased dry layer resistance to mass transfer after more efficient excipient crystallization [
Partially crystalline formulations
For formulations with crystallizable solutes, there is an additional critical consideration, that is, solute + water secondary crystallization.
The timing of an excipient crystallization can be important in some cases. It has been suggested, for example, that the crystallization of a bulking agent during cooling can be beneficial in minimizing vial breakage. A case study that describes vial breakage as the result of annealing, and prevention of the vial breakage using step-wise cooling, is provided [
From a practical perspective, when selecting set points for the freezing segment of a freeze-drying cycle for a formulation containing a crystallizable solute, it is necessary to choose a temperature and dwell time for a stepwise cooling program. These parameters should ideally lie between the equilibrium secondary melting temperature (e.g., mannitol + ice melting) and the glass transition temperature (Tg’), and can be guided by DSC and/or low-temperature XRD experiments. However, these are initial recommendations that should be fine-tuned based on experimental observations for each specific formulation. The question regarding hold time is less straightforward due to the limited research on the kinetics of solute crystallization in vials during freeze-drying [
Regarding final freezing temperature and hold time, Tang and Pikal[
To demonstrate potential applications of the freezing model, freezing times are calculated for different experimental protocols. Two shelf ramp rates and different vials and fill volumes are considered. The heat transfer coefficient, which was determined experimentally for the SCHOTT 6R vial, is assumed to be similar to other vials used in the simulations. The results are presented in Fig.
Freezing time to reach -44.8 °C is calculated using the freezing model [
Figure
Note that freezing model data for high-fill volume products need to be used carefully since the model does not account for the time of ice propagation. Additional soak time (about 30 min) can be added to calculated values shown in Fig.
The temperature of the fully frozen product is assumed to be -44.8° C rather than -45° C. Indeed, the product temperature is slowly approaching the final shelf temperature (-45° C) during the solid cooling stage in most cases. The final temperature change between -44.8° C and -45° C takes a significant amount of time and is not practical to be accounted for in real applications.
Since primary drying is usually the longest step and common risks, include collapse or meltback, this segment of the freeze-drying process has attracted the most effort. The critical first step in establishing primary drying conditions is selecting the target product temperature, commonly chosen as 2°C below the critical product temperature. Once the target product temperature is identified, shelf temperature and chamber pressure combinations are evaluated to establish a primary drying design space. An experimental approach for investigating the design space would require the manufacture of multiple batches [
While reducing primary drying time would require running the process at a higher temperature, there is an upper limit for a product temperature from a product perspective. The upper-temperature limit is defined by critical product temperature. This section discusses the identification of a target product temperature for two main types of formulations.
Tang and Pikal[
Nevertheless, the recommendation by Tang and Pikal [
Recent work by M.Pikal group showed that the safety margin could be calculated for a given product using a combination of statistical approaches (accounting for the variability of process parameters, vial heat transfer coefficients, and cake resistances) and a steady-state model of primary drying [
While critical product temperature can be measured in many cases by FDM and/or DSC, it may be worthwhile to confirm the critical product temperature by performing freeze-drying cycle(s) with the product in vials at the target fill volume at the product temperature close to or/and exceeding the FDM/DSC-determined Tc. Such experiments may show that the product could tolerate product temperature higher than per FDM/DSC measurements. In this respect, optical coherence tomography, which has been applied for 3-dimensional imaging of pharmaceutical formulations in vials during freeze-drying [
Spatial temperature heterogeneity within the product in a vial should be considered in experimental monitoring of the product temperature during freeze-drying. The temperature at the sublimation surface is lower than at the bottom, with larger temperature gradients observed at aggressive primary drying conditions and higher fill volumes [
As recommended by Tang and Pikal[
In most cases, three main set points define primary drying: chamber pressure, shelf temperature, and primary drying time. The transition from freezing to the primary drying step is usually straightforward, with a vacuum applied at the end of the freezing segment, followed by heating the shelf to the pre-determined set-point, usually at the ramp rate of 0.5 or 1 °C/min. The heating power of commercial freeze-dryers can limit the ramp rate due to the high mass of shelves and product vials. Also, a fast heating rate may compromise the ability of the condenser to maintain the temperature below -40°C, and pressure control could be lost due to the high sublimation rate at the initial step. Chamber pressure during primary drying is almost universally maintained between 50 and 200 mTorr, with 100 to 150 mTorr representing a typical range for high Tg’ products. Such pressure range provides a compromise between the need to accelerate ice sublimation, which usually requires a lower pressure, and improves heat transfer from shelf to product, which benefits from higher pressure. Per Tang and Pikal [
Also, note that a minimum sustainable pressure value depends on the equipment, sublimation rate, and chamber load, as discussed later in the section.
As a starting point, chamber pressure for primary drying can be selected using the following equation [
where
A common approach for the shelf temperature program during primary drying is maintaining the same temperature during the entire primary drying. However, in some (rare) cases, variable shelf temperature during primary drying can be beneficial to accelerate drying while keeping the product temperature below the critical value. Such an approach can be easily executed in laboratory-scale experiments but requires caution in a manufacturing environment to minimize errors in programming multiple primary drying steps.
Two parameters, chamber pressure and shelf temperature, define product temperature and duration of the primary drying for a given product and freeze-dryer. The product temperature at the sublimation interface is always lower than the shelf temperature during the sublimation stage, and the difference can sometimes reach more than 40°C.
As an efficient way to select the initial combination of chamber pressure and shelf temperature for a particular product and freeze-dryer, we recommend using a heat/mass transfer quasi-steady-state mathematical model as the first step. The basis for the model can be found in [
STca Lyo is the Excel-based steady-state primary drying model [
VMCa Lyo is a Python™ based steady-state primary drying model based on the same assumptions as those in the STca Lyo model. The model was designed to execute multiple scenarios that enable the creation of a design space for input parameters. This model uses “while loops” as its solver to increase or decrease the product temperature until it satisfies the conditions.
LyoPRONTO [
Inputs in primary drying model: dry layer resistance
Resistance of the dry product layer to the flow of water vapor depends primarily on the composition of the formulation and the dry layer thickness. The resistance can depend on the product history during freezing/annealing and primary drying, in particular, if the product experience change in the phase state (e.g., amorphous-to-crystalline transformation) or morphology (e.g., as a result of microcollapse) (Fig.
Rp for amorphous (left) and crystalline (right) formulations.
Top: Product dry layer resistance, Rp, as measured by MTM in model solutions. Graph is prepared from data reported in [
The vial heat transfer coefficient was calculated using the difference between shelf surface temperature and product temperature at the bottom of the vial (left panel, [
The Rp for these formulations is described by an empirical equation [
Rp = a + b*h/(1 + c*h), where h is a dry layer in cm, and a, b, and c are adjustable constants.
There are also cases when the Rp behavior deviates from the “standard” patterns. An example of such unusual behavior is presented in Fig.
Inputs in primary drying model: vial heat transfer coefficients
According to M.Pikal [
As described by [
Measuring shelf surface temperature is difficult, especially for fully loaded dryers. As an alternative, the inlet temperature of heat transfer fluid is used to calculate Kv (Fig.
According to [
Inputs in the primary drying model: minimum controllable pressure and maximum sublimation rate for a given freeze-dryer
Two critical characteristics of freeze-dryers are needed for the successful scale-up and transfer of lyophilization processes: minimum controllable pressure (or maximum sublimation rate at a given pressure) and maximum sublimation rate (typically due to condenser overload) for a particular dryer. The common understanding is that the dryer's performance could be limited by 1) the onset of choked flow, which limits the ability to control pressure, or by condenser capacity, where condenser temperature increases excessively. Due to geometric differences and limitations in the design laboratory, pilot and commercial dryers could respond differently to sublimation rates [
Minimum controllable pressure Pmin as a function of normalized (to total shelf area) sublimation rate for laboratory freeze-dryer Lyostar II (0.43 m2), pilot dryer Lyomax 6 (5.85 m2), and commercial-scale freeze-dryer Lyomax 42(41.85 m2).
Note that normalized sublimation rate values, plotted in Fig.
The normalized sublimation rate of 1.5 kg/hr/m2 could appear to be very high and nonrealistic. It corresponds to shelf temperature values above 40°C and pressures above 200 mT cycle conditions for the products with moderate cake resistance values (15 Torr*hr*cm2 at 1 cm for 10% solids, calculated as an example). Product temperatures, in this case, could exceed -10°C and stay just below the formulation's melting point during primary drying. While cycle conditions discussed above were not common in the past, in recent days and, especially in the future, one should expect more aggressive cycles to be implemented using bulking agents and freeze-drying well above Tg’. Most modern freeze-dryers can support high sublimation rates (up to 1.5 kg/hr/m2).
Verification of computational models
With Rp and Kv established and knowing the limitation of the freeze-dryer, primary drying conditions can be established using a computer model. Several primary drying-based models are listed in Table
Comparison of primary drying computer models for Lyostar II, using 5% mannitol, 2-ml vial, fill of 1.35 mL, with Tsh = 15C and Pch = 225 mTorr
| Computer model | Tpr (center), °C | Time (center), h | Tpr (edge) | Time (edge) |
|---|---|---|---|---|
| VMCa Lyo | -8.6 | 8.7 | -5.7 | 7.0 |
| LyoPRONTO Lyo | -8.8 | 8.6 | -5.8 | 6.8 |
| STCa Lyo | -8.6 | 8.8 | -6.0 | 7.0 |
For any computer model to be valid, it is essential to confirm that computational results agree with the experiment. There are several publications in which different computer models of primary drying were compared with experiments. Specifically, a non-steady state PASSAGE model, which solves the heat and mass transfer equations in frozen and dried regions of a single vial by finite element formulation in 2-D axisymmetric space, has been verified for several freeze-dried products in glass vials [
In this study, the STCa Lyo model is compared with the experiment for four products (Table
Input parameters for calculations of product temperature for materials in Fig.
| Material | Fill volume, mL | Solids content,% | Bulking agent | Annealing | Vial size*, mL | Input parameters | |
|---|---|---|---|---|---|---|---|
| Kv *104, Cal/cm^2/s | Rp, Torr*hr*cm^2/g | ||||||
| Amorphous-low solids content | 5.0 | 3.21 | Dextran | No | 20 | A = 1.496 B = 22.276 C = 2.497 | R0 = 0.396 R1 = 19.983 R2 = 17.379 |
| Crystalline-amorphous-low solids content | 4.0 | 3.41 | Glycine | Yes | 10P | A = 0 B = 70.000 C = 7.981 | R0 = 0 R1 = 3.592 R2 = 0.155 |
| Amorphous-high solids content | 5.5 | 13.16 | N/a | No | 10 | A = 1.430 B = 3.226 C = 2.745 | R0 = 0 B = 19.427 C = 2.437 |
| Crystalline-amorphous-high solids content | 1.0 | 10.16 | Mannitol | Yes | 2 | A = 0.532 B = 55.845 C = 5.854 | R0 = 0 R1 = 55.838 R2 = 0 |
*All vials were manufactured by Schott, except 10P vial (10 mL Pinko)
Comparison of experimental product temperature profiles during primary drying with the STCa model predictions: overlay of calculated and actual product temperatures for low solids content materials (amorphous-left upper figure (
Primary drying model vs. experiment: product temperature and primary drying duration, based on the results presented in Fig.
| Product | Measurements | Tpr, °C | Primary Drying Time, h | |||
|---|---|---|---|---|---|---|
| Beginning of PD (set point is reached) | Middle of PD ( approximately 60% of PD) | Product T, experiment (offset) | Pirani, experiment | model | ||
| Amorphous-low solids content | Experiment | -46.10 | -42.80 | 45.7 | 46.4 | 40.3 |
| STCa Lyo model | -44.90 | -42.85 | ||||
| Crystalline-amorphous-low solids content | Experiment | -34.57 | -28.10 | 14.9 | 13.4 | 14.3 |
| STCa Lyo model | -33.21 | -28.21 | ||||
| Amorphous-high solids content | Experiment | -22.0 | -17.0 | 16.7 | 19.8 | 13.5 |
| STCa Lyo model | -19.70 | -17.22 | ||||
| Crystalline-amorphous-high solids content | Experiment | -29.5 | -13.70 | 13.0 | 13.2 | 12.3 |
| STCa Lyo model | -27.23 | -13.34 | ||||
Overall, the STCa model, and by extension, two other models from Table
All cycles were performed above Tg’ of formulations but below collapse (measured by freeze-drying microcopy) temperature.
Data of Table
Primary drying database for laboratory-scale LyoStar 2 freeze-dryer
To build the database, the following variables are included (Table
product type, which defines dry layer resistance. The Rp could also depend on the cycle conditions, namely cooling/annealing conditions and the shelf temperature during primary drying. To account for the impact of the primary drying shelf temperature, two types of Rp for sucrose formulations are included: below Tc and above Tc.
Kv, which depends on vial size, chamber pressure, and the type of a freeze-dryer; in this database Kv for LyoStarII are used.
Fill volumes.
The number of vials is fixed to achieve the maximum load for LyoStar for each vial size, which is 1500 vials for 2 ml vials, 675 vials for 10 ml vials, and 420 vials for 20 mL vials.
Ranges of input parameters for primary drying database
| Input parameter | Range | Comment |
|---|---|---|
| Shelf temperature | -35 to 50°C | 5°C step |
| Chamber pressure | 20 to 450 mTorr | 20 mTorr step at 20 to 100 mTorr, 25 mTorr step above 100 |
| Vial type (nominal fill capacity) | 2, 10, 20 mL | See Table |
| Fill volume | 0.67 to 20.9 mL | See Table |
| Formulation | 5% mannitol; 5, 10, 20 wt% sucrose; Formulation-1 Formulation-2 | See Table Formulation-1 (3.5% solid): 2.5% glycine, 0.5% Sucrose, 0.4% protein, and a 0.1% buffer; Formulation-2 (10% solid): 4% mannitol, 1% Sucrose, and 5% protein |
These parameters are used to calculate product temperature, primary drying time, and sublimation rates for the center and edge vials for 46,962 product/primary drying set-points combinations and presented as a database. Needless to say, it would be impossible to cover all combinations of input parameters. Nevertheless, the range of parameters selected here should cover most practical cases. A user could bracket a particular input parameter if a particular condition is not covered in the database. In some cases, two or more brackets could be required. Several examples of using the database are given later in the paper.
The discussion in [
An essential practical advancement is developing an Excel-based computational model to calculate secondary drying conditions [
Secondary drying hold times for 5, 10, and 15% sucrose ((a), (c), and (e) panels respectively) as a function of shelf temperature to achieve residual moisture of 0.2% (grey), 0.5% (orange) and 1% (blue). The panels (b,d,f) represent the total secondary drying time (including ramp 0.2°C/min) for the same products. Calculations were made using Kg0 (pre-exponential factor [
Figure
Kinetics of water removal during secondary drying of product (small molecule)
Effect of secondary drying conditions on moisture of crystalline/amorphous product
Kinetics of water removal for amorphous (left panel, the formulation contains 2% of small molecule and 4% stabilizer) and semi-crystalline (right panel, the formulation contains 4% mannitol, 1% stabilizer, and 1% protein) products. No annealing was used in the product shown in the left panel, while 2 h annealing step at -15°C was used in the semi-crystalline product.
For amorphous products (about 6% solids), shown in Fig.
This paper considers examples of several hypothetical scenarios, although they do not cover all possible applications. The main starting points for selecting set-points for all three segments of the freeze-drying cycle include formulation description (crystalline/amorphous, total solid content), vials size, and fill volume. The selection of primary drying conditions starts with establishing the target product temperature for primary drying, Tt. For partially crystalline and amorphous formulations, the Tt is commonly selected as Tsc-2C and Tc-2C, respectively, although other approaches can also be used, as outlined below in example 2.3.
A 20°C load temperature, 0.5°C/min cooling rate, and a freezing temperature of -45°C are recommended for the freezing cycle. Based on Fig.
Next, the target product temperature is selected. The database has two product temperatures: the edge and center vial. The use of the edge vial is recommended as the safest approach. For example, 1, Tt = -5°C for the edge vial, based on the eutectic temperature for binary water/mannitol solutions of -2.2°C [
Three product temperatures (edge) are selected as -5.01, -5.11, and -5.03C, which are closest to, but slightly lower than the Tt. The former selection (Tp = -5.01C) results in an operational cycle, as shown in the last column of the database, while the cycle “will not work” for the last two product temperatures (-5.11 and -5.03C). The two cycles “will not work” because the recommended chamber pressure for these options would be lower than the minimal maintainable pressure for this freeze-dryer (Table
Process parameters for primary drying of 5% mannitol solution taken from the database. 10% edge effect (10% of edge vials received 50% more heat than center vials) was considered in calculations of the total sublimation rate for the fully loaded dryer (3shelvesx500 vials = 1500 of 2-mL vials)
| Process Parameters | Primary drying cycle | ||
|---|---|---|---|
| Case | 1.1 | 1.2 | 1.3 |
| Product T, °C (edge) | -5.01 | -5.11 | -5.03 |
| PD time, h (center) | 8.6 | 8.7 | 8.7 |
| Chamber pressure, Torr | 0.4 | 0.1 | 0.08 |
| Shelf T, C | 10 | 30 | 35 |
| Sublimation rate, kg/hr | 3.60E-01 | 3.12E-01 | 3.08E-01 |
| Pmin, Torr (from Fig. | 0.127 | 0.113 | 0.111 |
Due to the possible formation of mannitol hemihydrate [
Total cycle time would be 8.5 + 1 + 11 + 3.25 = 23.74 ~ 24 h.
Using input parameters for the model (see appendix, tables
Design space for the case described in Table
A
2.1 Freeze-drying conditions for a model “5% sucrose” formulation with 1.35 ml fill, conservative cycle
Cooling the condenser and pulling the vacuum to the set point typically takes about 1 h for a new dryer.
Select the corresponding formulation from the menu as “5% Sucrose below Tc”. Select fill volume: 1.35 mL in this example. Select product temperature with a value close to but lower than the critical product temperature (Tc=-32C, and the corresponding Tt=-34C). Select three different product temperatures around the target product (Tt =-34C in this example), and check the last column to ensure it shows “operational”. In this particular case, 3 closest Tpr are -34.43, --35.28, and -35.32C. All three options give “Operational” conditions. The recommended shelf T/chamber pressure combinations are provided in Table
Primary drying process parameters for case 2.1
| Process Parameters | Primary drying cycle | ||
|---|---|---|---|
| Case | 2.1.1 | 2.1.2 | 2.1.3 |
| Product T, C (edge) | -34.43 | -35.28 | -35.32 |
| PD time, h (center) | 60.3 | 57.5 | 568.5 |
| Chamber pressure, Torr | 0.08 | 0.06 | 0.15 |
| Shelf T, C | -30 | -30 | -35 |
| Sublimation rate, kg/hr | 0.0575 | 0.0603 | 0.00655 |
| Pmin (from Fig. | 0.0388 | 0.0396 | 0.0241 |
Total cycle time for 5% sucrose based formulation at about 1 cm cake height would be 2.67 + 1 + 78 + 11 = 92.67 ~ 93 h or about 4 days.
The calculated cycle with primary drying 2.1.2. option would still be long, with PD time approaching 58 h. There are at least two ways to reduce PD time without changing the composition of the dried formulation, i.e., either use higher concentration and lower fill volume or accept more aggressive PD conditions with the product temperature slightly above the Tc. These cases are described as Examples 2.2 and 2.3, respectively.
2.2 Primary drying conditions for a model formulation with 10% sucrose, 0.67 ml fill, conservative cycle.
Using the same approach as in Example 2.1 but with different inputs (10% sucrose, 0.67 ml fill, before Tc), the three Tpr (edge) closest to Tt = -34C are -34.14, -35.00, and -35.24C. The “-35.00” option “will not work because the corresponding chamber pressure would be too low (40 mTorr) to be controlled if the freeze-dryer is fully loaded. The latter option (Tpr = -35.24C) would correspond to the primary drying time (center vial) of > 300 h, which is practically unacceptable. Therefore, the recommended primary drying conditions would be Tsh = -30C and Pch = 60 mTorr, with the primary drying (center vial) of 30.8 h, corresponding to an almost 2 × reduction in the primary drying time compared with Example 2.1.
2.3. Primary drying conditions for a model formulation with 5% sucrose, 1.35 ml fill, aggressive cycle
For aggressive PD (5% sucrose after Tc option, see resistance coefficients in table
Product temperature and primary drying time for Examples 2.2 and 2.3
| Cycle output | 5% Below Tc, 1.35 ml fill (3.1) | 10% below Tc, 0.67 ml (3.2) | 5% Above Tc, 1.35 ml fill (3.3) | |||
|---|---|---|---|---|---|---|
| Tsh | -30 | -30 | -15 | |||
| Pch | 80 | 60 | 125 | |||
| Center | Edge | Center | Edge | Center | Edge | |
| Product T, C | -35.4 | -34.4 | -35.2 | -34.1 | -33.1 | -31.8 |
| PD time, h | 60.3 | 48.7 | 30.8 | 25.3 | 16.6 | 12.3 |
Note that performing the PD with product T slightly above the Tc would result in microcollapse, while the macroscopic collapse would still be avoided. The product appearance, in this case, would still be acceptable in most markets [
Cake appearance of 5% (top picture, left vial) and 15% (top picture, right vial) of sucrose lyophilized below microscopic collapse temperature (shelf temperature of -28°C and pressure of 50 mTorr resulting in product temperature below -36°C and 33°C for 5% and 15% of sucrose respectively). Lyophilized cakes are shown upside down to demonstrate no collapse at the bottom of cake. Middle and bottom pictures are 5% and 15% sucrose formulations, respectively, lyophilized at or slightly above microscopic collapse temperature (-32°C for 5% and -30°C for 15%) using shelf temperature of -10°C and pressure of 100 mTorr.
Note also that secondary drying for the “after Tc” cycle would be longer because of a lower specific surface area (because of microcollapse) and correspondingly lower water desorption rate. Usually, secondary drying time should be increased by approximately a factor of 2.
Practical advice on the selection of freeze-drying process conditions from the seminal paper published in [
While huge with almost 47,000 combinations calculated, the primary drying database has two limitations. One is related to Rp vs. dry layer height patterns, with typical behavior for amorphous and crystalline formulations described by empirical questions. This approach leaves out products with “atypical” Rp patterns, and the current database might be less accurate in calculating primary drying conditions for such “atypical” formulations. However, based on the authors' collective experience, we argue that most real pharmaceutical formulations demonstrate “normal” Rp behavior. A more significant limitation is that the Kv values used in the database represent laboratory-scale LyoStar 2 freeze-dryers, and therefore the primary drying calculations are directly applicable to lab-scale freeze-drying only. Nevertheless, the approach described here can be used to build similar databases for the pilot- and commercial-scale freeze-dryers, provided that Kv values are determined.
To conclude, this paper may supplement the knowledge of scientists/formulators with significant freeze-drying experience and those new to this field. The database provides specific primary drying conditions for various formulations, vials, and fill volumes and examples of entire freeze-drying cycles to cover freezing/annealing, primary drying, and secondary drying conditions. For an advanced user, the database could represent a user-friendly tool to estimate the design space quickly and can also be used as a template to build a similar database to cover pilot- and commercial-size freeze-dryers.
We should mention that one of the important advances in lyophilization process development is an implementation of an instrument that allows direct measurement of sublimation rate (Tunable Diode Laser Absorption Spectroscopy- TDLAS ([
Also, the implementation of direct measurements of pore structure (micro CT) would enable a further tuning of heat transfer models by accurate estimation of resistance of porous cake.
Below is the link to the electronic supplementary material.
Supplementary file1 (DOCX 18 kb)
Supplementary file2 (XLSX 9.61 mb)
The manuscript is based on the data generated from Vito Maglio’s Capstone Project at Purdue University. The authors acknowledge Prof. William Clark for his support of this project.
Authors also would like to acknowledge Steve Nail for very valuable suggestions for the text improvements.
Serguei Tchessalov: Paper leadership and substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; and Drafting the work or revising it critically for important intellectual content; and Final approval of the version to be published; and Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Evgenyi Shalaev: Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; and Drafting the work or revising it critically for important intellectual content; and Final approval of the version to be published; and Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Bakul Bhatnagar: Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; and Drafting the work or revising it critically for important intellectual content; and Final approval of the version to be published; and Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Petr Kazarin: Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; and Drafting the work or revising it critically for important intellectual content; and Final approval of the version to be published; and Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Alina Alexeenko: Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; and Drafting the work or revising it critically for important intellectual content; and Final approval of the version to be published; and Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Ekneet Sahni: Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; and Drafting the work or revising it critically for important intellectual content; and Final approval of the version to be published; and Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Vito Maglio: Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; creating the excel based database; and Drafting the work or revising it critically for important intellectual content; and Final approval of the version to be published; and Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Serguei Tchessalov
Vito Maglio: N/A.
Petr Kazarin: N/A.
Alina Alexeenko: Paid employee of LyoHUB, Purdue University, at the time of the project/paper drafting process.
Bakul Bhatnagar
Ekneet Sahni: N/A.
Evgenyi Shalaev
The authors declare that the data supporting the findings of this study are available within the paper and its supplementary information files. Data sets generated during the current study are also available from the corresponding author on reasonable request.
Serguei Tchessalov
Vito Maglio: N/A.
Petr Kazarin: N/A.
Alina Alexeenko: N/A.
Bakul Bhatnagar
Ekneet Sahni: N/A.
Evgenyi Shalaev
ES is an employee of AbbVie and may own AbbVie stock. He participated in design of the study, in the collection, analysis, and interpretation of data, and in writing, reviewing, and approval of the final publication. ST, VM, and BB are employees of Pfizer, PK and AA are employees of Purdue University, and Ekneet Sahni is an employee of Regeneron. They do not have any conflicts of interest
Abbvie contributed to the design of the study, data collection, analysis and interpretation, manuscript preparation, and approval of the publication; Abbvie did not provide financial support for the study.
In pharmaceutical freeze-drying literature, “eutectic” is commonly used to describe solute + water crystallization. This “eutectic” terminology, when applied to a typical pharmaceutical solution with several solutes present, is not correct from the physical chemistry perspectives. Eutectic is a non-variant (invariant) point on a temperature-composition (T-x) phase diagram of N-component system (where N is a total number of components including both solutes and solvent), which correspond to a co-existence of N + 1 phases (N is the number of components) for any condensed system, based on Gibbs phase rule. It means that for a binary system (e.g., mannitol + water), mannitol + water crystallization can be described as “eutectic” crystallization, while if the solution contains a third component (e.g., mannitol + sucrose + water), the “eutectic” term would require crystallization of all three components, i.e., mannitol, sucrose, and water. For such ternary system as water + mannitol + sucrose, the eutectic would mean co-existence of 4 phases (ice, crystalline mannitol, crystalline sucrose, and liquid). Such phase composition has not been observed experimentally even in such relatively simple systems as water + mannitol + sucrose. In essentially all real pharmaceutical solutions with N > 2, there is no eutectic crystallization during freeze-drying, at least eutectic in phys chem sense. We would recommend that a pharmaceutical scientist, who prefers to use “eutectic” to describe solute + water crystallization for aqueous solutions with 2 or more solutes, would add an appropriate disclaimer (e.g., [
There are also at least two other definitions of 'critical cooling rate'. The most common use of the 'critical cooling rate' terminology is in cryobiology, in which it describes primary water crystallization, i.e., freezing (water-to-ice transformation). This is different from the secondary solute + water crystallization, which takes place after the primary water crystallization. In a relatively dilute aqueous solution, 'critical cooling rate' for primary water crystallization would probably exceed thousands of degrees Celsius per minute, while 'critical cooling rate' for the secondary crystallization, as described in this paper, could be lower than a few degrees Celsius per minute. We would like to emphasize that we are using 'critical' in the physical–chemical sense, akin to 'critical micelle concentration', and not in the regulatory sense of a critical process parameter. This is a property of the formulation and in some cases, the cooling rate can be critical to quality attributes and needs to be evaluated. Another use of the same terminology of 'critical cooling rate' was introduced by [
Our recommendation of -10 °C for mannitol annealing is based on understanding that the highest degree of crystallization and lowest amount of mannitol hemi-hydrate is based on practical understanding of such a behavior of mannitol. The temperatures above -10 C can induce the risk of potential melting in the edge vials. In addition, higher annealing temperatures could mitigate the formation of mannitol hemi-hydrate. Additionally, we advise utilizing elevated secondary drying temperatures, as it promotes a more comprehensive elimination of mannitol hemi-hydrate.
Our recommendation for re-freezing after annealing is made with caution and with the consideration that our proposed methods may need to cater to a variety of formulations, many of which may not be completely crystalline. In case of completely crystalline products, direct initiation of primary drying post-annealing is theoretically feasible. However, for biological products that are not entirely crystalline, ensuring that the product is fully solidified through re-freezing could be an essential step.
Moreover, in some formulations with low collapse temperature, directly transitioning to primary drying from annealing might pose a risk. The rapid decrease in pressure when initiating vacuum could potentially induce degassing and/or (in extreme cases) boiling when the pressure drops below the water vapor pressure. This, in turn, can negatively impact visual appearance of the product, and also lead to a high mass flow rate during primary drying, potentially resulting in difficulties in maintaining the desired pressure setpoint.
Therefore, a "safe" approach, which includes a re-freezing step after annealing is proposed. This will help to accommodate the range of products and formulations that may be subject to the described process.
However, we acknowledge that for specific products and formulations where it's possible, avoiding the re-freezing step could save process time. Such an approach should indeed be validated through careful testing for each specific formulation.
The supplemental data has been replaced with the updated file.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
10/7/2024
A Correction to this paper has been published: 10.1007/s11095-024-03768-1
Supplementary file1 (DOCX 18 kb)
Supplementary file2 (XLSX 9.61 mb)
The authors declare that the data supporting the findings of this study are available within the paper and its supplementary information files. Data sets generated during the current study are also available from the corresponding author on reasonable request.